In Brief Sharon Wilks joins NEXT Oncology’s phase I clinical investigation team December 10, 2021Vol.47 No.45
Funding Opportunities FDA OCE invites white papers for applied research funding December 10, 2021Vol.47 No.45
Clinical Roundup Insights into T-cell exhaustion could improve cancer immunotherapies, Penn study finds December 10, 2021Vol.47 No.45
Clinical Roundup UK study identifies method of predicting treatment response in breast cancer December 10, 2021Vol.47 No.45
Clinical Roundup Researchers use genomics to match treatments to improved outcomes in metastatic breast cancer December 10, 2021Vol.47 No.45
Clinical Roundup Elacestrant may improve outcomes for patients whose metastatic breast cancers progressed on prior endocrine therapy December 10, 2021Vol.47 No.45
Clinical Roundup Breast cancer patients with ER mutations may benefit from early switch to Faslodex/Ibrance December 10, 2021Vol.47 No.45
Clinical Roundup Black women more likely to develop lymphedema following breast cancer treatment than white women December 10, 2021Vol.47 No.45
Clinical Roundup Studies show sustained benefits of Ayvakit in advanced systemic mastocytosis December 10, 2021Vol.47 No.45
Drugs & Targets FDA approves Rituxan plus chemo for pediatric cancer indications December 10, 2021Vol.47 No.45
